Today: 9 June 2026
Buffett Hands Off Berkshire: BRK.B Stock Slips as Greg Abel Takes the Helm
1 January 2026
2 mins read

Buffett Hands Off Berkshire: BRK.B Stock Slips as Greg Abel Takes the Helm

NEW YORK, January 1, 2026, 05:00 ET — Market closed

  • Berkshire’s Class A and Class B shares ended modestly lower in the last trading session of 2025 as Warren Buffett wrapped up his final day as CEO.
  • Greg Abel assumes the CEO role on Jan. 1 while Buffett remains chairman, keeping focus on continuity and capital allocation.
  • Investors are watching for early signals on the stock portfolio, buybacks and Berkshire’s next earnings update in late February.

Berkshire Hathaway Inc’s shares closed slightly lower on Wednesday as Warren Buffett wrapped up his last day as chief executive and handed the job to Greg Abel for Thursday.

The Class A stock dipped $600, or 0.1%, to $754,800 and the Class B stock (BRK.B) fell $1.06, or 0.2%, to $502.65, outperforming a 0.7% drop in the S&P 500.

The handoff ends Buffett’s six-decade run in the top job and shifts attention to how Berkshire operates without him in the CEO seat. Buffett, 95, will remain chairman and plans to keep working from Omaha, offering Abel support.

The stakes are high because Berkshire has become too large for small mistakes to stay small. A quarterly filing showed the conglomerate ended September with $381.7 billion of cash and equivalents, leaving investors focused on how the company deploys that money.

Abel, 63, joined Berkshire in 2000 through its MidAmerican Energy deal and has overseen the non-insurance businesses since 2018. Ajit Jain will keep day-to-day oversight of insurance, while NetJets chief executive Adam Johnson will oversee consumer products, services and retail units.

A key open question is who ultimately steers Berkshire’s $283.2 billion stock portfolio — including major holdings such as Apple and American Express — after investment manager Todd Combs left this month for JPMorgan Chase. Buffett has previously said Abel could handle the role.

CFRA Research analyst Cathy Seifert said investors would likely applaud a management style that “buttons things up,” even as Berkshire preserves its decentralized structure. Courthouse News

Berkshire has also been reshaping its finance bench: an SEC filing said Chief Financial Officer Marc Hamburg will resign as CFO on June 1, 2026, with Charles C. Chang set to succeed him, while Hamburg remains until his retirement on June 1, 2027.

For shareholders, the near-term question is less about day-to-day operations — Abel already runs much of the business — and more about capital allocation. Berkshire earns investment income on cash and insurance “float,” the premium money it holds before claims get paid, so interest-rate moves can ripple into results.

Before the next session, traders will watch whether the year-end dip holds as U.S. markets reopen Friday after the New Year’s Day holiday. The Class B shares sit about 7% below their 52-week high of $542.07 and about 14% above their 52-week low of $440.10, while analysts tracked by Investing.com put the average 12-month price target near $529.

On the macro front, the Labor Department is scheduled to release the December employment report on January 9 at 8:30 a.m. ET, according to the agency’s calendar. The jobs data often shifts rate expectations that feed into Berkshire’s investment income.

Weekly jobless claims fell to 199,000 for the week ended Dec. 27, and the Federal Reserve has already started cutting rates while debating how much further to go, Reuters reported. Markets have leaned heavily on labor data to price the next move.

Stock Market Today

  • Uranium Energy Shares Fall 17% on Larger Q3 Loss Despite New Production Start
    June 9, 2026, 4:11 PM EDT. Uranium Energy Corp shares fell 17% to $10.43 after reporting a fiscal third-quarter net loss of $52.3 million, up from $30.2 million a year earlier. The Texas-based uranium miner began production at its Burke Hollow project, using in-situ recovery (ISR), which extracts uranium by dissolving ore underground. The company ended the quarter with $794 million in liquid assets and no debt. Weak sales of purchased uranium inventory contributed to the loss, dropping gross profit from sales to $10 million from $24.5 million last year. CEO Amir Adnani highlighted ongoing challenges in uranium conversion, a key step for nuclear fuel production. Despite falling shares, UEC expects production to rise in the fourth quarter as new facilities at Burke Hollow and Christensen Ranch operate fully. Market uranium prices remained stable near $85.70 per pound.

Latest articles

Dow Edges Up 16 Points, Nasdaq Falls After Bell

Dow Edges Up 16 Points, Nasdaq Falls After Bell

9 June 2026
Tech stocks plunged, dragging the Nasdaq down 1.21% as investors dumped AI and chip shares ahead of key inflation data and after President Trump called for a U.S. response to Iran’s downing of a U.S. helicopter; the Dow edged up just 16 points as volatility spiked to its highest since April 7.
POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

POET Technologies Shares Drop; AI Photonics Trade Faces Pressure

9 June 2026
POET Technologies plunged 13% to $10.65 as renewed class-action reminders and April’s Marvell/Celestial AI order cancellation kept legal and execution risks in focus, outweighing a $50 million Lumilens order and $400 million financing, while broader AI chip stocks also slumped.
Uranium Energy Drops 17% After Reporting Q3 Loss

Uranium Energy Drops 17% After Reporting Q3 Loss

9 June 2026
Uranium Energy shares plunged 17% to $10.43 after reporting a wider Q3 net loss of $52.3 million and no uranium inventory sales, overshadowing the start of production at Burke Hollow; heavy volume and a sharper drop than peers reflected investor concerns over execution risks and near-term earnings despite strong cash and no debt.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop